NCNMGF
BOLT icon

Nano-Cap New Millennium Growth Fund’s Bolt Biotherapeutics BOLT Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Hold
27,500
– – 0.08% 120
2026
Q1 		$111K Buy
27,500
+7,000
+34% +$36.5K 0.1% 130
2025
Q4 		$112K Buy
+20,500
New +$110K 0.1% 144

Other funds holding BOLT

SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's BOLT Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund held its Bolt Biotherapeutics (BOLT) position steady in Q2 2026 at 27,500 shares worth $106K. The position accounts for 0.08% of the portfolio, ranked #120.

Nano-Cap New Millennium Growth Fund first reported a position in BOLT in Q4 2025 and has held it in 3 quarters since. The position peaked at $112K in Q4 2025. 23 funds tracked by Wall St. Rank hold BOLT as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 27,500 shares of Bolt Biotherapeutics worth $106K as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund left its Bolt Biotherapeutics share count unchanged in Q2 2026.
  • Bolt Biotherapeutics made up 0.08% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #120 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Bolt Biotherapeutics in Q4 2025 and has held it in 3 quarters since.
  • Nano-Cap New Millennium Growth Fund's Bolt Biotherapeutics position peaked at $112K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.